Drug
ACT-709478 clinical trials
Also written NBI-827104 and ACT-709478.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Neurocrine Biosciences (3) · Idorsia Pharmaceuticals Ltd. (3)
Related medicines
As reviewed, each with the page that says it.
- One of Calcium Channel Blockers source
Studies
Open first, then newest update. How each study uses ACT-709478 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During SleepTerminatedPhase 2Neurocrine BiosciencesNCT05301894Written as NBI-827104
- Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During SleepCompletedPhase 2Neurocrine BiosciencesNCT04625101Written as NBI-827104
- Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential TremorCompletedPhase 2Neurocrine BiosciencesNCT04880616Written as NBI-827104
- A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy MenCompletedPhase 1Idorsia Pharmaceuticals Ltd.NCT04123288Written as ACT-709478
- Study to Evaluate Safety and Tolerability of ACT-709478 in Healthy SubjectsCompletedPhase 1Idorsia Pharmaceuticals Ltd.NCT03165097Written as ACT-709478
- A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy PatientsCompletedPhase 2Idorsia Pharmaceuticals Ltd.NCT03239691Written as ACT-709478 for oral use
Codes
What other systems call ACT-709478 · ClinicalTrials.gg INT001331
- MeSH (NLM) C000707407ACT-709478Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3Z7U1U8Z9EAPINOCALTAMIDEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000707407 | ACT-709478 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3Z7U1U8Z9E | APINOCALTAMIDE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.